Ask AI

On-Demand Webcast

Share

Program Content

Activities

  • Targeted ADCs in HER2pos Bladder Cancer
    Personalizing Treatment of HER2-Positive Advanced Bladder Cancer: Expert Guidance on the Latest Evidence for HER2-Targeted ADCs
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 16, 2026

    Expires: September 15, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.